Atlas Trials

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Clinical trial NCT00005783 · COMPLETED

Trial details

NCT number
NCT00005783
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemoglobin SC DiseaseSickle Cell Anemia
Start date
2000-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.